News from AIDS 2012

The 19th International AIDS Conference (AIDS 2012) took place in Washington, USA, 22nd-27th July 2012.

As the official online partner for scientific reporting, NAM published original news reporting and free email bulletins.

aidsmap news from AIDS 2012

Low levels of innate immune activation and high levels of gut antibodies may protect people from HIV

Several research papers published in the last month have reported strong correlations between specific immune responses and protection against HIV infection or its effects. These include

Published
24 August 2012
By
Gus Cairns
Could North Africa and the Middle East be a new hotspot for HIV in gay men?

HIV experts are concerned that the largely Islamic countries of the middle east and north Africa may be set to follow east and south-east Asia in seeing

Published
10 August 2012
By
Gus Cairns
Most young Thai MSM define as heterosexual, even if they mainly have sex with men

A large, randomised sample of 21-year-old Thai men, presented at the 19th International AIDS Conference in Washington recently, has found that by far the largest risk

Published
10 August 2012
By
Gus Cairns
Needs of adolescents with HIV need greater attention, AIDS 2012 hears

Complications of HIV infection among adolescents in resource-poor settings include malnutrition, chronic lung disease and tuberculosis as well as the long-term side effects of drugs - including lipodystrophy, peripheral

Published
09 August 2012
By
Carole Leach-Lemens
US youth, heterosexual men and African Americans losing out on HIV treatment benefits

A new study presented at the 19th International AIDS Conference shows that young people, African Americans, and heterosexual men have particularly low rates of retention in care and

Published
08 August 2012
By
Gus Cairns
What kind of prevention do gay men need?

A number of presentations at the 19th International AIDS Conference explored the 'hyperepidemic' of HIV amongst men who have sex with men, and especially black MSM. A paper

Published
06 August 2012
By
Gus Cairns
Depending on how it's defined, between 13% and 46% of American gay men report intimate partner violence

A study which aimed to produce a definition of intimate partner violence (physical, sexual, or psychological harm caused by a current or former partner) that would be

Published
03 August 2012
By
Roger Pebody
Male partner involvement improves HIV testing during pregnancy

Studies presented at the Nineteenth International AIDS Conference (AIDS 2012) in Washington DC called attention to the benefits of increasing male involvement in prevention of mother-to-child transmission (PMTCT)

Published
02 August 2012
By
Kelly Safreed-Harmon
HIV testing at immunisation clinics: an opportunity to identify women and infants who are falling through the cracks?

Research from Malawi further strengthens the case for using infant immunisation clinics as a key site for maternal and early infant HIV diagnosis, the Nineteenth International AIDS

Published
02 August 2012
By
Kelly Safreed-Harmon
Higher CD4 count preserves ability to work and educate children

A higher CD4 cell count benefits the household economically and is associated with better educational opportunities for the children in the household, according to findings from a

Published
02 August 2012
By
Carole Leach-Lemens
← First12345...7Next →

Sign up today

Sign up for our regular email bulletins:

Find out more and sign up to the full range of aidsmap email bulletins >

AIDS 2012 tweets

More coverage of the conference

Two other official partners of the conference are providing coverage and analysis online.

Clinical Care Options (CCO) provide audio highlights, capsule summaries and downloadable slidesets, while the Kaiser Family Foundation provide webcasting from conference sessions.

NAM is partnering with UNICEF to deliver the AIDS 2012 bulletins, which have also been made possible thanks to support from Bristol-Myers Squibb and Vestergaard Frandsen. NAM’s wider conference news reporting services have been supported by Abbott, Boehringer Ingelheim, Janssen, Roche and ViiV Healthcare.